Author:
Nakamura Takashi,Fukiage Masafumi,Higuchi Megumi,Nakaya Akihiro,Yano Ikuya,Miyazaki Jun,Nishiyama Hiroyuki,Akaza Hideyuki,Ito Toshihiro,Hosokawa Hiroyuki,Nakayama Toshinori,Harashima Hideyoshi
Reference38 articles.
1. BCG immunotherapy of bladder cancer: 20years on;Alexandroff;Lancet,1999
2. Bacillus Calmette–Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine;Kawai;Cancer Sci.,2013
3. Analyses of the effects of intravesical Bacillus Calmette–Guerin (Tokyo 172 strain) therapy of superficial bladder cancer;Akaza;Nihon Hinyokika Gakkai Zasshi,1989
4. Ablative and prophylactic effects of BCG Tokyo 172 strain for intravesical treatment in patients with superficial bladder cancer and carcinoma in situ of the bladder. Bladder cancer BCG Study Group;Akaza;Nihon Hinyokika Gakkai Zasshi,1992
5. Incidence and treatment of complications of bacillus Calmette–Guerin intravesical therapy in superficial bladder cancer;Lamm;J. Urol.,1992
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献